These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34861180)

  • 1. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study.
    Shi T; Pan J; Katikireddi SV; McCowan C; Kerr S; Agrawal U; Shah SA; Simpson CR; Ritchie LD; Robertson C; Sheikh A;
    Lancet Respir Med; 2022 Feb; 10(2):191-198. PubMed ID: 34861180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study.
    Shi T; Pan J; Vasileiou E; Robertson C; Sheikh A;
    Lancet Respir Med; 2022 Apr; 10(4):347-354. PubMed ID: 35033224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of COVID-19 hospitalizations among school-aged children in Scotland: A national incident cohort study.
    Shi T; Pan J; Moore E; Katikireddi SV; Docherty AB; Fenton L; McCowan C; Agrawal U; Kerr S; Shah SA; Stock SJ; Simpson CR; Robertson C; Sheikh A;
    J Glob Health; 2022 Sep; 12():05044. PubMed ID: 36134546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
    Agrawal U; Katikireddi SV; McCowan C; Mulholland RH; Azcoaga-Lorenzo A; Amele S; Fagbamigbe AF; Vasileiou E; Grange Z; Shi T; Kerr S; Moore E; Murray JLK; Shah SA; Ritchie L; O'Reilly D; Stock SJ; Beggs J; Chuter A; Torabi F; Akbari A; Bedston S; McMenamin J; Wood R; Tang RSM; de Lusignan S; Hobbs FDR; Woolhouse M; Simpson CR; Robertson C; Sheikh A
    Lancet Respir Med; 2021 Dec; 9(12):1439-1449. PubMed ID: 34599903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study.
    Simpson CR; Robertson C; Vasileiou E; Moore E; McCowan C; Agrawal U; Stagg HR; Docherty A; Mulholland R; Murray JLK; Ritchie LD; McMenamin J; Sheikh A
    Lancet Digit Health; 2021 Aug; 3(8):e517-e525. PubMed ID: 34238721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
    Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
    Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
    Twohig KA; Nyberg T; Zaidi A; Thelwall S; Sinnathamby MA; Aliabadi S; Seaman SR; Harris RJ; Hope R; Lopez-Bernal J; Gallagher E; Charlett A; De Angelis D; Presanis AM; Dabrera G;
    Lancet Infect Dis; 2022 Jan; 22(1):35-42. PubMed ID: 34461056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Katikireddi SV; Cerqueira-Silva T; Vasileiou E; Robertson C; Amele S; Pan J; Taylor B; Boaventura V; Werneck GL; Flores-Ortiz R; Agrawal U; Docherty AB; McCowan C; McMenamin J; Moore E; Ritchie LD; Rudan I; Shah SA; Shi T; Simpson CR; Barreto ML; Oliveira VA; Barral-Netto M; Sheikh A
    Lancet; 2022 Jan; 399(10319):25-35. PubMed ID: 34942103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
    Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
    Vasileiou E; Simpson CR; Shi T; Kerr S; Agrawal U; Akbari A; Bedston S; Beggs J; Bradley D; Chuter A; de Lusignan S; Docherty AB; Ford D; Hobbs FR; Joy M; Katikireddi SV; Marple J; McCowan C; McGagh D; McMenamin J; Moore E; Murray JL; Pan J; Ritchie L; Shah SA; Stock S; Torabi F; Tsang RS; Wood R; Woolhouse M; Robertson C; Sheikh A
    Lancet; 2021 May; 397(10285):1646-1657. PubMed ID: 33901420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.
    Sheikh A; Kerr S; Woolhouse M; McMenamin J; Robertson C;
    Lancet Infect Dis; 2022 Jul; 22(7):959-966. PubMed ID: 35468332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake, effectiveness and safety of COVID-19 vaccines in children and young people in Scotland: Protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II).
    Adeloye D; Katikireddi SV; Woolford L; Simpson CR; Shah SA; Agrawal U; Richie LD; Swann OV; Stock SJ; Robertson C; Sheikh A; Rudan I
    J Glob Health; 2021; 11():05026. PubMed ID: 35003715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people.
    Shah SA; Brophy S; Kennedy J; Fisher L; Walker A; Mackenna B; Curtis H; Inglesby P; Davy S; Bacon S; Goldacre B; Agrawal U; Moore E; Simpson CR; Macleod J; Cooksey R; Sheikh A; Katikireddi SV
    EClinicalMedicine; 2022 Jul; 49():101462. PubMed ID: 35611160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study.
    Florentino PTV; Millington T; Cerqueira-Silva T; Robertson C; de Araújo Oliveira V; Júnior JBS; Alves FJO; Penna GO; Vital Katikireddi S; Boaventura VS; Werneck GL; Pearce N; McCowan C; Sullivan C; Agrawal U; Grange Z; Ritchie LD; Simpson CR; Sheikh A; Barreto ML; Rudan I; Barral-Netto M; Paixão ES
    Lancet Infect Dis; 2022 Nov; 22(11):1577-1586. PubMed ID: 35952702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era.
    Shah SA; Robertson C; Rudan I; Murray JL; McCowan C; Grange Z; Buelo A; Sullivan C; Simpson CR; Ritchie LD; Sheikh A
    J Glob Health; 2022; 12():05008. PubMed ID: 35356660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
    Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
    Aveyard P; Gao M; Lindson N; Hartmann-Boyce J; Watkinson P; Young D; Coupland CAC; Tan PS; Clift AK; Harrison D; Gould DW; Pavord ID; Hippisley-Cox J
    Lancet Respir Med; 2021 Aug; 9(8):909-923. PubMed ID: 33812494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland.
    Amele S; Kibuchi E; McCabe R; Pearce A; Henery P; Hainey K; Fagbamigbe AF; Kurdi A; McCowan C; Simpson CR; Dibben C; Buchanan D; Demou E; Almaghrabi F; Anghelescu G; Taylor H; Tibble H; Rudan I; Nazroo J; Bécares L; Daines L; Irizar P; Jayacodi S; Pattaro S; Sheikh A; Katikireddi SV
    J Epidemiol Community Health; 2023 Oct; 77(10):641-648. PubMed ID: 37524538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
    HDR UK COALESCE Consortium
    Lancet; 2024 Feb; 403(10426):554-566. PubMed ID: 38237625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.